CSS
MIST icon

Cubist Systematic Strategies’s Milestone Pharmaceuticals MIST Stock Holding History

Cubist Systematic Strategies’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,938
Closed -$73K – 3249
2024
Q4 		$73K Buy
+30,938
New +$53.1K ﹤0.01% 2742
2023
Q3 		– Sell
-12,957
Closed -$36.9K – 3711
2023
Q2 		$36.9K Buy
12,957
+4,037
+45% +$15.2K ﹤0.01% 3130
2023
Q1 		$35.1K Sell
8,920
-81,974
-90% -$300K ﹤0.01% 3613
2022
Q4 		$360K Buy
90,894
+79,294
+684% +$417K ﹤0.01% 3245
2022
Q3 		$107K Buy
+11,600
New +$88K ﹤0.01% 3993

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's MIST Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Milestone Pharmaceuticals (MIST) in Q1 2025, closing a stake of 30,938 shares — an estimated $73K sold.

Cubist Systematic Strategies first reported a position in MIST in Q3 2022 and held it in 5 quarters. The position peaked at $360K in Q4 2022. 43 funds tracked by Wall St. Rank hold MIST as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Milestone Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,938 Milestone Pharmaceuticals shares in Q1 2025, an estimated $73K.
  • Cubist Systematic Strategies first reported a position in Milestone Pharmaceuticals in Q3 2022 and held it in 5 quarters.
  • Cubist Systematic Strategies's Milestone Pharmaceuticals position peaked at $360K in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.